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Abstract  Percutaneous  ablation  (radiofrequency  or  cryotherapy)  of  bone  tumors  is  most  often
performed  for  palliative  purposes.  Many  studies  have  shown  that  percutaneous  ablation  of
a painful  bone  metastasis  can  signiﬁcantly  and  sustainably  reduce  symptoms.  It  is  therefore
an alternative  to  radiotherapy  and  to  long-term  opiates.  Percutaneous  ablation  can  also  be
performed  for  curative  purposes.  In  this  situation,  its  efﬁcacy  has  however  only  been  studied
to a  very  small  extent  (apart  from  radiofrequency  ablation  of  osteoid  osteomas  in  which  the
success rate  is  almost  100%).  In  our  experience,  the  success  rate  after  radiofrequency  ablation
of a  bone  metastasis  is  75%  if  it  is  less  than  3  cm  in  diameter  and  fall  signiﬁcantly  over  this
(to 40%,  P  =  0.04).  This  treatment  can  therefore  be  justiﬁed  in  oligometastatic  patients  whose
disease is  progressing  slowly.  Its  beneﬁt  on  survival  has  however  not  been  assessed  in  this
selected  population.  Whether  it  is  performed  for  palliative  or  curative  reasons,  percutaneous
ablation should  ideally  be  followed  by  an  injection  of  cement  if  the  metastasis  being  treated
is lytic  and  located  in  a  bone,  which  is  subject  to  mechanical  forces.  The  aim  of  consolidating
cementoplasty  is  to  counterbalance  the  additional  risk  of  fracture  due  to  destruction  of  the
percutaneously  ablated  bone.
©  2014  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
The  tumor  destruction  techniques  used  routinely  to  treat  bone  metastases  are  the  ‘ther-
mal’  ablation  techniques  such  as  radiofrequency  and  cryotherapy.
Radiofrequency  ablation  involves  positioning  a  needle  electrode  under  CT  guidance
inside  the  tumor  in  order  to  deliver  an  alternating  current  of  400  to  500  kHz.  The  regions
through  which  this  radiofrequency  beam  passes  are  subject  to  ionic  agitation,  which  heats
the  tissue  as  a  result  of  friction  between  the  particles.  The  desired  aim  is  to  expose
the  tumor  cells  to  a  temperature  over  60 ◦C,  which  almost  immediately  and  irreversibly
denatures  them.
∗ Corresponding author.
E-mail address: frederic.deschamps@igr.fr (F. Deschamps).
http://dx.doi.org/10.1016/j.diii.2014.04.004
2211-5684/© 2014 Éditions franc¸aises de radiologie. Published by Elsevier Masson SAS. All rights reserved.
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to  mechanical  forces  (Fig.  2).  The  aim  of  consolidat-60  
In  the  same  way,  cryotherapy  requires  one  or  more  nee-
les  to  be  positioned  within  the  tumor  under  CT  guidance.
he  principle  of  this  technique  is  based  on  the  Joule-
hompson  effect:  rapid  decompression  of  argon  gas  at  the
nd  of  the  needle  reaches  a  temperature  of  −180 ◦C  in  a  few
econds.
These  ‘thermal’  ablation  techniques,  which  were  ini-
ially  used  as  curative  treatment  for  liver  tumors  [1,2],
re  now  being  used  for  other  sites  including  kidney  [3,4],
ung  [5,6]  and  bone  [7—11]  tumors.  Heat  ablation  of  bone
umors  has  several  speciﬁc  features  compared  to  other
natomical  sites.  The  ﬁrst  is  related  to  the  electrical  and
hermal  properties  of  the  bone  structure.  Trabecular  bone
onducts  heat  less  well  than  muscle  and  the  volume  of  the
rea  destroyed  is  therefore  less  in  bone  than  in  muscle.
n  addition,  cortical  bone  has  heat  insulating  activity  [12],
hich  protects  neighboring  structures,  provided  that  cor-
ical  bone  is  preserved.  This  heat  insulation  can  also  be
sed  advantageously  to  treat  internal  bone  tumors  thanks
o  the  ‘oven  effect’,  which  concentrates  heat  on  the  tumor
ite  as  opposed  to  other  organs.  The  other  speciﬁc  fea-
ure  of  thermal  ablation  of  bone  metastases  is  due  to  the
act  that  the  indications  are  rarely  curative  but  usually
alliative  in  patients  with  pain.  Very  few  studies  are  avail-
ble  on  the  curative  efﬁcacy  of  ablation  of  bone  tumors,
robably  because  the  indications  for  this  are  very  rare  and
nly  one  study  has  been  published  on  the  subject  [9]. This
as  a  retrospective  assessment  of  the  efﬁcacy  of  curative
ryotherapy  on  37  bone  metastases  in  17  oligometastatic
atients.  The  local  control  rate  was  68%  at  1  year,  all  bone
umor  histologies  combined,  probably  because  the  indica-
ions  for  its  use  were  extremely  limited.  In  our  experience
122  bone  metastases  treated  with  curative  purposes  in  89
atients  between  September  2001  and  February  2012),  the
omplete  response  rate  was  67%  at  1  year  and  the  tumor
ize  of  under  20  mm  was  predictive  of  success  (P  =  0.001).
ashima  et  al.  [13]  showed  that  complete  curative  treat-
ent  of  bone  metastases  from  a  hepatocellular  carcinoma
as  an  independent  predictive  indicator  for  survival  in  this
opulation  with  a  response  rate  and  3  year  median  sur-
ival  of  10.4%  and  16.8  months,  respectively  if  treatment
as  complete  compared  to  0%  and  6.5  months  with  incom-
lete  treatment  (P  <  0.04).  Several  recent  studies  however
13—15]  have  demonstrated  the  analgesic  effectiveness  of
adiofrequency  and  cryotherapy  ablation  on  painful  bone
umors.  One  prospective  multicenter  trial  has  been  car-
ied  out  on  palliative  care  for  bone  tumors  [14],  which
ncluded  43  patients  with  lytic  bone  tumors  between  1.4
Table  1  Change  in  pain  on  visual  analog  scale  (VAS)  after  rad
Number
of
patients
[Refe-
rence]
Number
of
tumors
Before
RF
Number  of  week(s)  after  RF
1  4  
VAS  43  [14]  43  7.9  7.3  (P  =  0.2)  4.5  (P  < 0.0
29  [13]  6.1  1.8  (P  <  0.001)
30  [15]  34  8.3  4.9  3.6  
i
r
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t  18  cm  in  size,  causing  pain  scoring  an  average  of  7.9
oints  on  a  pain  assessment  scale  ranging  from  1  to  10
oints.  In  this  study,  radiofrequency  ablation  achieved  a  3
oint  reduction  in  pain  severity  in  40  %  of  patients  after
 week,  in  55%  after  3  weeks,  and  in  84%  at  some  time  after
reatment.  Other  more  recent  studies  report  similar  results
Table  1).
The  aim  of  thermal  ablation  in  the  treatment  of  bone
ain  is  not  to  destroy  the  entire  tumor  but  rather  to  target
he  margins  between  tumor  and  bone  structures  in  order
o  try  to  destroy  endosteal  nerve  endings  which  are  prob-
bly  greatly  involved  in  the  origin  of  pain  as  a  result  of
heir  stimulation  by  chemicals  such  as  prostaglandins  and
radykinine,  substance  P  or  histamine,  which  are  released
y  the  destroyed  bone.  Whilst  the  speciﬁc  heat  sensitiv-
ty  of  nerves  is  used  in  the  treatment  of  pain,  it  should
e  remembered  that  all  neuronal  structures  including  the
pinal  cord  are  very  heat  sensitive.  Temperatures  of  over
5 ◦C  or  under  10 ◦C  are  considered  to  be  toxic  to  the  bone
arrow  and  peripheral  nerves.  As  a  result,  the  procedure
ust  be  performed  extremely  cautiously  for  spinal  tumors.
 vertebral  body  tumor  can  be  treated  with  heat  ablation
herapy  provided  that  cortical  bone  is  still  present  in  the
osterior  vertebral  wall  and  it  is  more  than  1  cm  from  the
pinal  cord.  It  would  appear  somewhat  arbitrary  to  believe
hat  heat  is  dissipated  by  thermal  convection  as  a  result
f  CSF  circulation  or  the  periarachnoid  venous  plexus  is
ufﬁcient  to  protect  the  spinal  cord  as  suggested  by  some
uthors.  In  addition,  a  high  complication  rate  has  been
eported  in  the  treatment  of  vertebral  tumors.  Cryotherapy
ppears  to  be  more  appropriate  than  radiofrequency  abla-
ion  for  these  bone  sites  close  to  neurological  structures.
he  area  of  freezing  which  develops  around  the  tip  of  the
eedle  can  occasionally  be  visualized  on  CT  during  the  pro-
edure  (Fig.  1).  As  peroperative  cryotherapy  is  less  painful
han  radiofrequency  ablation,  conscious  patient  sedation  is
ossible.
Cryotherapy  therefore  offers  a clear  advantage  for
T  and  clinical  monitoring  of  complications  compared  to
adiofrequency  ablation.
Regardless  of  whether  administered  palliatively  or
uratively,  heat  ablation  should  ideally  be  followed  by
njection  with  cement  when  the  metastasis,  which  has
een  treated,  is  lytic  and  located  in  a  bone  subjectiofrequency  (RF)  ablation  of  painful  bone  metastases.
8  12  24
001)  3.5  (P  <  0.0001)  3.0  (P  <  0.0001)  1.5  (P  <  0.0005)
2.1
ng  cementoplasty  is  to  counterbalance  the  additional
isk  of  fracture  caused  by  the  thermal  destruction  of
one.
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Figure 1. Analgesic cryotherapy for a paravertebral metastasis of a lung carcinoma. Procedure performed under clinical monitoring
(conscious sedation) and CT (visualizing the hyodense ice ball) throughout the procedure to reduce the risks of spinal burns.
Figure 2. Curative radiofrequency ablation for a single bone metastasis of a renal cancer. Injection of cement into the osteolytic area at
b
t
p
Fthe end of the procedure to reduce the risk of fracture.
Conclusion
The  effectiveness  of  heat  ablation  techniques  as  cura-
tive  treatment  for  bone  metastases  has  still  been  poorly
documented  in  the  literature.  It  would  appear  that
a  size  of  under  2  cm  is  a  good  prognostic  indica-
tor.  Conversely,  its  analgesic  effectiveness  on  painful
a
b
fony  metastases  has  now  been  well  established  and
his  is  a  genuine  treatment  option  for  patients  in
ain,  either  alone  or  in  combination  with  radiotherapy.
inally,  heat  ablation  techniques  have  no  consolidating
ction  and  should  be  combined  with  cementoplasty  for
one  metastases  in  areas  subject  to  high  mechanical
orces.
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TAKE-HOME  MESSAGES
• The  percutaneous  ablation  techniques  used  to  treat
bone  tumors  are  radiofrequency  and  cryotherapy
ablation.
• These  techniques  can  reduce  bone  related  pain.
• They  can  also  be  used  curatively  for  small  tumors.
•
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3.  C  (Fig.  6a  and  b).  MRI  is  the  reference  investigation  after
curative  treatment.  It  visualizes  the  treatment  area  and
allows  investigation  for  a  persistent  image  abnormality,
which  could  suggest  residual  tumor.  CT  scan  usually  doesConsolidating  cementoplasty  should  be  combined  for
tumors  in  ‘weight-bearing’  bone.
linical case
orty-ﬁve-year-old  male  patient  undergoing  surgery
or  renal  cancer  3  months  ago.  Staging  assessment:  4
entimeter-sized  lung  metastases  and  two  asymmetrical
one  metastases  (8th  rib  and  neck  of  femur),  progressing
lowly.
uestions
.  What  management  would  you  propose  for  the  femoral
metastasis  (Fig.  3)?
A.  Monitoring  only  as  this  is  an  asymptomatic  metastasis.
B.  Radiofrequency  (or  cryotherapy)  ablation  to  reduce
the  risk  of  local  progression  in  a  patient  with  long  life
expectancy.
.  Would  you  perform  a  cementoplasty?
A.  No,  as  there  is  no  mechanical  threat.
B.  Yes,  as  radiofrequency  (or  cryotherapy)  ablation
leaves  the  treated  bone  fragile  and  increases  the  risk
of  fractures  in  ‘weight-bearing’  structures.
.  What  imaging  investigation  would  you  request  for  local
monitoring?
A.  None.
B.  Enhanced  CT.
C.  MRI  centered  on  the  femoral  neck.
nswers.  B  (Fig.  4).  Local  control  of  a  bony  metastasis  should
be  considered  in  patients  with  a  long  life  expectancy
in  order  to  reduce  the  risk  of  progression,  which  could
igure 3. Asymptomatic osteolytic lacuna in the right femoral
eck. Figure 4. Radiofrequency needle in situ.
result  in  local  complications  (pathological  fracture,
invasion/compression  of  adjacent  structures).  Radiofre-
quency  or  cryotherapy  ablation  is  effective  treatments
to  destroy  small  metastases  (<  2  cm).
.  B  (Fig.  5).  Destruction  of  the  bone  matrix  around
bone  metastasis  treated  by  radiofrequency  or  cryother-
apy  ablation,  causes  fragile  bone  which  carries  a  risk
of  secondary  bone  fracture.  Combination  preventative
cementoplasty  is  justiﬁed  in  bone  subjected  to  high
mechanical  forces.igure 5. Cement injection at the end of the procedure.
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[15] Thanos L, Mylona S, Galani P, Tzavoulis D, Kalioras V, TantelesFigure 6. MRI, T1 (a) and T2 (b) weighted coronal images at
2 months showing the treatment area which widely covers the
treated metastasis.
not  visualize  the  treatment  area,  particularly  if  combi-
nation  cementoplasty  has  been  performed.Disclosure of interest
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concerning  this  article.663
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